Benzinga - Tue, 30 Mar 2021 16:09:58 -0400
Benzinga - Tue, 23 Mar 2021 05:16:23 -0400
Benzinga - Fri, 05 Mar 2021 06:37:42 -0400
load more
Sector: Health Care.Industry: Pharmaceuticals
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-06-08
REV
Q4 2020Est.ActualSurprise
EPS-3.650
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
TERNTerns Pharmaceuticals-4.94%

Terns Pharmaceuticals Company Questions & Answers

Q

How do I buy Terns Pharmaceuticals (TERN) stock?

A

You can purchase shares of Terns Pharmaceuticals (NASDAQ: TERN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Terns Pharmaceuticals's (TERN) main competitors?

A

Other companies in Terns Pharmaceuticals’s space includes: Novo Nordisk (NYSE:NVO), Reata Pharmaceuticals (NASDAQ:RETA) and Johnson & Johnson (NYSE:JNJ).

Q

What is the target price for Terns Pharmaceuticals?

A

The latest price target for Terns Pharmaceuticals (NASDAQ: TERN) was reported by JP Morgan on 2021-03-02. The analyst firm set a price target for 32.00 expecting TERN to rise to within 12 months (a possible 47.81% upside). 3 analyst firms have reported ratings in the last year.

Q

How much is Terns Pharmaceuticals (TERN) stock ?

A

The stock price for Terns Pharmaceuticals (NASDAQ: TERN) is $21.65 last updated Today at 8:00:02 PM.

Q

When is the next Terns Pharmaceuticals (TERN) dividend?

A

There are no upcoming dividends for Terns Pharmaceuticals.

Q

When is Terns Pharmaceuticals (NASDAQ:TERN) reporting earnings?

A
Terns Pharmaceuticals’s Q1 earnings are confirmed after-market from now on June 8, 2021.
Q

When is the upcoming split for TERN?

A

There is no upcoming split for Terns Pharmaceuticals.